Skip to main content
Livermore
Livermore
ZHEN

Fifth Third Bancorp

SEC CIK
0000035527
Latest filing
Aug 5, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Fifth Third Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
29,244
Value
$18.2M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of REGN by Fifth Third Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202629,244$18.2M<0.1%−5,666−16.2%ReducedHolders
Q1 202634,910$27.0M<0.1%+19,485+126.3%AddedHolders
Q4 202515,425$11.9M<0.1%+3,362+27.9%AddedHolders
Q3 202512,063$6.78M<0.1%+1,929+19.0%AddedHolders
Q2 202510,134$5.32M<0.1%+2,443+31.8%AddedHolders
Q1 20257,691$4.88M<0.1%−952−11.0%ReducedHolders
Q4 20248,643$6.16M<0.1%−1,753−16.9%ReducedHolders
Q3 202410,396$10.9M<0.1%+2,143+26.0%AddedHolders
Q2 20248,253$8.67M<0.1%−119−1.4%ReducedHolders
Q1 20248,372$8.06M<0.1%−240−2.8%ReducedHolders
Q4 20238,612$7.56M<0.1%−62−0.7%ReducedHolders
Q3 20238,674$7.14M<0.1%+13+0.2%AddedHolders
Q2 20238,661$6.22M<0.1%+178+2.1%AddedHolders
Q1 20238,483$6.97M<0.1%−297−3.4%ReducedHolders
Q4 20228,780$6.33M<0.1%+47+0.5%AddedHolders
Q3 20228,733$6.02M<0.1%+192+2.2%AddedHolders
Q2 20228,541$5.05M<0.1%−4,279−33.4%ReducedHolders
Q1 202212,820$8.95M<0.1%−337−2.6%ReducedHolders
Q4 202113,157$8.31M<0.1%+697+5.6%AddedHolders
Q3 202112,460$7.54M<0.1%+3,983+47.0%AddedHolders
Q2 20218,477$4.74M<0.1%−11,425−57.4%ReducedHolders
Q1 202119,902$9.42M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.